Literature DB >> 3920690

Continuous low-level apomorphine administration induces motor abnormalities and hallucinogen-like behaviors.

R E Davis, W W Sant, G Ellison.   

Abstract

Continuous low-level (0.825 mg/kg/h for 20 h) administration of AP through SC in-dwelling silicone reservoirs in the rat induced behavioral and biochemical changes that were similar to those induced by low levels (0.1 mg/kg) of acutely administered AP (decreased behavioral activity and decreased dopamine metabolism in the striatum). With longer periods of continuous AP exposure (40 h or more) the activity-depressing effects of low-level AP diminished. Concurrently a novel behavioral syndrome emerged characterized by limb flicks, body shakes, sudden orienting responses, and motor abnormalities, such as tremors of the jaw muscles, chewing movements, prominent tongue extensions, and body 'tics'. This behavioral syndrome became more apparent following cessation of drug treatment. These novel behavioral changes, which were accompanied by increased behavioral responsiveness to acutely administered AP and amphetamine, were correlated with increased levels of dopamine, homovanillic acid, and 3,4-dihydroxyphenylacetic acid in the striatum but not the nucleus accumbens. This novel behavioral syndrome appears to reflect a rebound increase in dopaminergic mechanisms in striatum following their chronic suppression by low levels of AP.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3920690     DOI: 10.1007/bf00427314

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  27 in total

1.  Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs.

Authors:  I Creese; D R Burt; S H Snyder
Journal:  Science       Date:  1976-04-30       Impact factor: 47.728

2.  Dextroamphetamine. Evaluation of psychomimetic properties in man.

Authors:  J D Griffith; J Cavanaugh; J Held; J A Oates
Journal:  Arch Gen Psychiatry       Date:  1972-02

3.  The distribution of apomorphine in rat brain: possible behavioral correlates.

Authors:  M Melzacka; G Wiszniowska; J Vetulani
Journal:  Pol J Pharmacol Pharm       Date:  1978 Mar-Jun

4.  Blockage of amphetamine induced motor stimulation and stereotypy in the adult rat following neonatal treatment with 6-hydroxydopamine.

Authors:  I Creese; S D Iversen
Journal:  Brain Res       Date:  1973-06-15       Impact factor: 3.252

Review 5.  Effect of apomorphine on schizophrenic symptoms.

Authors:  R C Smith; C Tamminga; J M Davis
Journal:  J Neural Transm       Date:  1977       Impact factor: 3.575

Review 6.  The involvement of serotonin in the mechanism of central action of apomorphine.

Authors:  M Grabowska
Journal:  Pol J Pharmacol Pharm       Date:  1976 May-Jun

7.  Opposed stages of continuous amphetamine administration: parallel alterations in motor stereotypies and in vivo spiroperidol accumulation.

Authors:  G Ellison; W Morris
Journal:  Eur J Pharmacol       Date:  1981-09-11       Impact factor: 4.432

8.  Schizophrenic symptoms improve with apomorphine.

Authors:  C A Tamminga; M H Schaffer; R C Smith; J M Davis
Journal:  Science       Date:  1978-05-05       Impact factor: 47.728

9.  On the significance of endogenous 3-methoxytyramine for the effects of centrally acting drugs on dopamine release in the rat brain.

Authors:  B H Westerink; S J Spaan
Journal:  J Neurochem       Date:  1982-03       Impact factor: 5.372

10.  The late stage following continuous amphetamine administration to rats is correlated with altered dopamine but not serotonin metabolism.

Authors:  G Ellison; R Ratan
Journal:  Life Sci       Date:  1982-08-23       Impact factor: 5.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.